CDK10 and melanoma: In this study, the finding of up-regulation of CDK10 expression in vitiligo support the evidence that patients with vitiligo have a reduced risk of overall internal malignancies (Bae et al., 2019), melanoma, and non-melanoma skin cancer (Paradisi et al., 2014).